metformin has been researched along with gw9662 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, SC; Macfarlane, WM; Richardson, H; Smith, SA | 1 |
| Aoki, C; Hattori, Y; Jojima, T; Kasai, K; Nakano, A | 1 |
| Banerjee, A; Flynt, L; Ghosh, S; Mellema, M; Panettieri, RA; Shore, SA; Williams, E; Zhu, M | 1 |
| Emoto, M; Fukumoto, S; Imanishi, Y; Inaba, M; Ishimura, E; Koyama, H; Mori, K; Morioka, T; Motoyama, K; Nakatani, S; Ochi, A | 1 |
| Askari, VR; Mousavi, SH; Rahimi, VB | 1 |
| Askari, VR; Baradaran Rahimi, V; Mousavi, SH | 1 |
6 other study(ies) available for metformin and gw9662
| Article | Year |
|---|---|
Effects of rosiglitazone and metformin on pancreatic beta cell gene expression.
Topics: Active Transport, Cell Nucleus; Anilides; Animals; Cell Line; Cell Nucleus; DNA; Gene Expression; Glucose; Hepatocyte Nuclear Factor 3-beta; Homeodomain Proteins; Insulin-Secreting Cells; Metformin; Mice; Proinsulin; Promoter Regions, Genetic; Protein Binding; Rats; Rosiglitazone; Thiazolidinediones; Time Factors; Trans-Activators | 2006 |
Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Benzimidazoles; Benzoates; Biotransformation; Blotting, Western; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cytokines; Dose-Response Relationship, Drug; Gene Expression; Humans; Hypoglycemic Agents; Metformin; NF-kappa B; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2009 |
Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Anilides; Anti-Inflammatory Agents; Antimetabolites; Asthma; Cells, Cultured; Chromans; Cytokines; Enzyme Activators; Enzyme Inhibitors; Gene Knockdown Techniques; Humans; Hypoglycemic Agents; Inflammation Mediators; Metformin; Myocytes, Smooth Muscle; PPAR gamma; Pyrazoles; Pyrimidines; Respiratory System; Ribonucleotides; Rosiglitazone; Thiazolidinediones; Troglitazone; Vidarabine | 2011 |
Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.
Topics: alpha-2-HS-Glycoprotein; Anilides; Animals; Cell Line, Tumor; Diabetes Mellitus, Type 2; Gene Expression; Hepatocytes; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Mice; Mice, Inbred C57BL; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2014 |
Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study.
Topics: Aging; Anilides; beta-Galactosidase; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Ellagic Acid; Galactose; Glutathione; Glycation End Products, Advanced; Humans; Malondialdehyde; Mannitol; Metformin; Neuroblastoma; Protoporphyrins; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ.
Topics: Aging; Anilides; Animals; Apoptosis; Brain; Ellagic Acid; Galactose; Glutathione Peroxidase; Liver; Male; Malondialdehyde; Metformin; Mice; Models, Animal; Oxidative Stress; PPAR gamma; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |